Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$ 6,440	$ 4,744	$ 6,009
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for depreciation and net amortization	2,262	2,516	2,604
Provision (benefit) for deferred income taxes	(93)	(33)	400
Provision for loan losses	560	4,015	785
Deferred net loan origination costs	(417)	(514)	(443)
Proceeds from sales of loans held for sale	41,591	63,510	102,080
Originations of loans held for sale	(40,882)	(61,950)	(101,812)
Gain on sale of loans	(1,047)	(1,373)	(1,918)
Provision for (recapture of) mortgage servicing rights valuation allowance	19	(259)	199
Net loss on sale of premises and equipment	57	0	3
Realized gain on sale of securities available for sale	(3)	(12)	0
Net loss on sale and provision for write-down of foreclosed assets	65	301	443
Increase in cash surrender value of bank-owned life insurance	(404)	(402)	(407)
Gain on bargain purchase	0	0	(851)
Changes in operating assets and liabilities:
Accrued interest receivable	50	81	313
Other assets	80	1,590	386
Accrued expenses and other liabilities	757	820	(235)
Net cash provided by operating activities	9,035	13,034	7,556
Cash flows from investing activities:
Proceeds from maturities of securities available for sale	15,606	41,824	49,290
Proceeds from sale of securities available for sale	1,774	986	0
Proceeds from maturities of securities held to maturity	5,225	6,502	10,778
Payment for purchase of securities available for sale	(29,710)	(31,241)	(32,368)
Payment for purchase of securities held to maturity	(3,965)	(8,960)	(11,696)
Cash acquired on acquisitions	17,741	0	14,910
Net redemption (net purchase) of bank certificates of deposit	(1,188)	2,229	(1,981)
Net redemption (purchase) of FHLB stock	0	(50)	744
Net (increase) decrease in loans	4,339	(36,746)	(10,349)
Capital expenditures	(595)	(334)	(572)
Proceeds from sale of premises and equipment	7	0	0
Proceeds from sale of foreclosed assets	782	831	1,527
Purchase of bank-owned life insurance	0	(611)	0
Net cash provided by (used in) investing activities	10,016	(25,570)	20,283
Cash flows from financing activities:
Net increase (decrease) in non-interest-bearing deposits	8,269	12,825	(9,902)
Net decrease in interest-bearing deposits	(3,612)	(694)	(6,832)
Net decrease in Federal Home Loan Bank advances	(17,778)	(12,075)	0
Net increase (decrease) in other borrowings	(10,117)	(287)	1,037
Repayment of senior subordinated notes	0	(3,000)	0
Dividends declared	(1,316)	(1,289)	(1,247)
Proceeds from exercise of stock options			9
Purchase of treasury stock	(913)	(269)	(262)
Net cash used in financing activities	(25,467)	(4,789)	(17,197)
Net increase (decrease) in cash and cash equivalents	(6,416)	(17,325)	10,642
Cash and cash equivalents at beginning	31,522	48,847	38,205
Cash and cash equivalents at end	25,106	31,522	48,847
Cash paid during the year for:
Interest	4,632	5,645	7,177
Income taxes	2,560	759	2,146
Noncash investing and financing activities:
Loans charged off	969	4,743	1,332
Loans transferred to foreclosed assets	801	1,342	1,295
Loans originated on sale of foreclosed properties	43	234	490
Grants of unvested restricted stock at fair value	200	210	200
Vesting of restricted stock grants	203	165	116
Amortization of unrealized gain on securities held to maturity transferred from securities available for sale	$ 330	$ 420	$ 452